2009-08-012024-05-18https://scholars.lib.ntu.edu.tw/handle/123456789/708761Anti-Pancreatic Cancer Drug Development Based on Enhancing FasL-Induced Apoptosis and Evaluation Mechanisms and Combined Benefits with Chemotherapy Agents/Radiation Treatment